Footnotes
This manuscript has recently been accepted for publication in the ERJ Open Research. It is published here in its accepted form prior to copyediting and typesetting by our production team. After these production processes are complete and the authors have approved the resulting proofs, the article will move to the latest issue of the ERJOR online. Please open or download the PDF to view this article.
Conflicts of interest: N. Drick reports speaker fees for AstraZeneca. H. Suhling reports speaker fees for AstraZeneca, GlaxoSmithKline (GSK) and Novartis. J. Fuge reports speaker fees for AstraZeneca. T. Welte reports personal fees from AstraZeneca, GSK and Sanofi Aventis and his institution has received research grants from the German Ministry of Research and Education. L Brinkmann has no relevant conflicts of interest.
This is a PDF-only article. Please click on the PDF link above to read it.
- Copyright ©The authors 2023
This version is distributed under the terms of the Creative Commons Attribution Non-Commercial Licence 4.0. For commercial reproduction rights and permissions contact permissions{at}ersnet.org
